Title:
INTERLEUKIN-9 ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/246570
Kind Code:
A1
Abstract:
Provided are an antibody specifically binding to IL-9, a nucleic acid encoding the antibody, a vector comprising the nucleic acid, a host cell comprising the nucleic acid or the vector, a pharmaceutical composition comprising the antibody, and uses of the antibody and the pharmaceutical composition.
More Like This:
| WO/2023/150735 | SURROGATE CYTOKINE POLYPEPTIDES |
| WO/2000/044777 | ANTIBODIES SPECIFIC TO KDR AND USES THEREOF |
| WO/2014/097762 | ANTIBODY TO HIGHLY PATHOGENIC AVIAN INFLUENZA |
Inventors:
LAU HUNG YAN (CN)
LI CHIN YU (CN)
LI CHIN YU (CN)
Application Number:
PCT/CN2023/100022
Publication Date:
December 28, 2023
Filing Date:
June 13, 2023
Export Citation:
Assignee:
GUANGDONG KEGUANDA PHARMACEUTICAL TECH CO LTD (CN)
International Classes:
A61K39/395; A61P11/00; A61P35/02; A61P37/00; C07K14/52; G01N33/53
Domestic Patent References:
| WO2003086458A1 | 2003-10-23 |
Foreign References:
| CN1809383A | 2006-07-26 | |||
| CN110167592A | 2019-08-23 | |||
| CN112654363A | 2021-04-13 | |||
| CN104470950A | 2015-03-25 | |||
| US20160017025A1 | 2016-01-21 |
Attorney, Agent or Firm:
LIU , SHEN & ASSOCIATES (CN)
Download PDF: